Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2020 | 06-2020 | 04-2020 | 03-2020 | 07-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,317 | N/A | -4,410 | -4,410 | -4,862 |
| Depreciation Amortization | N/A | N/A | 0 | 0 | -37 |
| Other Working Capital | 520 | N/A | -299 | -299 | 1,230 |
| Other Operating Activity | 592 | 0 | 2,363 | 2,363 | 2,624 |
| Operating Cash Flow | $-205 | $N/A | $-2,346 | $-2,346 | $-1,045 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 101 | 0 | 105 | 105 | 234 |
| Investing Cash Flow | $101 | $N/A | $105 | $105 | $234 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 77 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 2,288 | 2,288 | 309 |
| Financing Cash Flow | $77 | $N/A | $2,288 | $2,288 | $309 |
| Beginning Cash Position | 90 | N/A | 43 | 43 | 545 |
| End Cash Position | 63 | N/A | 90 | 90 | 43 |
| Net Cash Flow | $-27 | $N/A | $48 | $48 | $-502 |
| Free Cash Flow | |||||
| Operating Cash Flow | -205 | N/A | -2,346 | -2,346 | -1,045 |
| Free Cash Flow | -205 | 0 | -2,346 | -2,346 | -1,045 |